Abbott Laboratories ( ABT +1.49%) more or less met analyst estimates in its first quarter, the results of which were ...

By Siddhi Mahatole and Puyaan Singh April 16 (Reuters) - Abbott cut its annual profit forecast on Thursday due to an impact ...

Abbott Laboratories stock has been punished hard in 2026, and the question is whether that punishment has overshot the ...

Abbott (ABT) drops 4.5% after earnings and lowered 2026 EPS guidance; see top healthcare ETFs with big ABT exposure and ...

By Diana Novak Jones CHICAGO, April 10 (Reuters) - A jury in Chicago on Friday said Abbott Laboratories must pay $70 million ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of hundreds of injuries and seven deaths worldwide—after some sensors showed they ...

Makuochi Echebiri is a News Writer for Collider. He has been interested in creative writing from as far back as high school, and he would consume pretty much anything that’s film or TV. However, his ...

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) has pulled back sharply in 2026. Our Wall St. price target for Abbott ...